Eicosanoid release is increased by membrane destabilization and CFTR inhibition in calu-3 cells

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Borot, Florence ^a   Vieu, Diane Lore ^a   Faure, Grazyna ^b   Fritsch, Janine ^a   Colas, Julien ^a   Moriceau, Sandra ^a   Baudouin Legros, Maryvonne ^a   Brouillard, Franck ^a   Ayala Sanmartin, Jesus ^b   Touqui, Lhousseine ^c   Chanson, Marc ^d   Edelman, Aleksander ^a   Ollero, Mario ^a  

^a INSERM   (France)

^b CNRS   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOLIC PHOSPHOLIPASE A2; ICOSANOID; INTERLEUKIN 8; LIPOCORTIN 1; METHYL BETA CYCLODEXTRIN; PROTEIN S 100; PROTEIN S 100A10; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CFTR PROTEIN, HUMAN; CHOLESTEROL; PHOSPHOLIPASE A2 GROUP IV; PHOSPHOLIPID;

ARTICLE; CELL STRAIN; CELL STRAIN CALU 3; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOGENESIS; MEMBRANE RESISTANCE; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SURFACE PLASMON RESONANCE; ANIMAL; CELL MEMBRANE; CHEMISTRY; KINETICS; METABOLISM; MOUSE; PROTEIN BINDING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CHOLESTEROL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EICOSANOIDS; GROUP IV PHOSPHOLIPASES A2; HUMANS; INTERLEUKIN-8; KINETICS; MEMBRANE MICRODOMAINS; MICE; PHOSPHOLIPIDS; PROTEIN BINDING; SURFACE PLASMON RESONANCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449566790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007116     Document Type: Article

References (59)

1. Machen TE (2006) Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 291: C218-230.
2. Rosenstein BJ, Zeitlin PL (1998) Cystic fibrosis. Lancet 351: 277-282.
3. Rubin BK (2003) A scientific koan: what is the cause of cystic fibrosis? Chest 123: 1792-1793.
4. Chmiel JF, Berger M, Konstan MW (2002) The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol 23: 5-27.
5. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J (2004) Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 31: 377-381.
6. Ratjen F (2006) What's new in CF airway inflammation: an update. Paediatr Respir Rev 7 Suppl 1: S70-72.
7. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, et al. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075-1082.
8. Rao S, Grigg J (2006) New insights into pulmonary inflammation in cystic fibrosis. Arch Dis Child 91: 786-788.
9. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, et al. (2000) Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 23: 121-127.
10. Di A, Brown ME, Deriy LV, Li C, Szeto FL, et al. (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8: 933-944.
11. Haggie PM, Verkman AS (2007) Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages. J Biol Chem 282: 31422-31428.
12. Yu H, Nasr SZ, Deretic V (2000) Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect Immun 68: 2142-2147.
13. Besancon F, Przewlocki G, Baro I, Hongre AS, Escande D, et al. (1994) Interferon-gamma downregulates CFTR gene expression in epithelial cells. Am J Physiol 267: C1398-1404.
14. Brouillard F, Bouthier M, Leclerc T, Clement A, Baudouin-Legros M, et al. (2001) NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta. J Biol Chem 276: 9486-9491.
15. Ollero M, Brouillard F, Edelman A (2006) Cystic fibrosis enters the proteomics scene: new answers to old questions. Proteomics 6: 4084-4099.
16. Bensalem N, Ventura AP, Vallee B, Lipecka J, Tondelier D, et al. (2005) Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knockout mice and patients. Mol Cell Proteomics 4: 1591-1601.
17. Touqui L, Rothhut B, Shaw AM, Fradin A, Vargaftig BB, et al. (1986) Platelet activation-a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 321: 177-180.
18. Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, et al. (1986) Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320: 77-81.
19. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353: 1711-1723.
20. Konstan MW, Walenga RW, Hilliard KA, Hilliard JB (1993) Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 148: 896-901.
21. Medjane S, Raymond B, Wu Y, Touqui L (2005) Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 289: L816-824.
22. Borthwick LA, McGaw J, Conner G, Taylor CJ, Gerke V, et al. (2007) The formation of the cAMP/protein kinase A-dependent annexin 2-S100A10 complex with cystic fibrosis conductance regulator protein (CFTR) regulates CFTR channel function. Mol Biol Cell 18: 3388-3397.
23. Chap H, Fauvel J, Gassama-Diagne A, Ragab-Thomas J, Simon MF (1991) Une homologie frappante entre le CFTR et les annexines. Medecine/Sciences 7: 8-9.
24. Bailleux A, Wendum D, Audubert F, Jouniaux AM, Koumanov K, et al. (2004) Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence. Biochem J 378: 307-315.
25. Wu T, Angus CW, Yao XL, Logun C, Shelhamer JH (1997) P11, a unique member of the S100 family of calcium-binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2. J Biol Chem 272: 17145-17153.
26. Bastian BC, Sellert C, Seekamp A, Romisch J, Paques EP, et al. (1993) Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction. J Invest Dermatol 101: 359-363.
27. Buckland AG, Wilton DC (1998) Inhibition of human cytosolic phospholipase A2 by human annexin V. Biochem J 329 (Pt 2): 369-372.
28. Liu J, Zhu X, Myo S, Lambertino AT, Xu C, et al. (2005) Glucocorticoid-induced surface expression of annexin 1 blocks beta2-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein. J Allergy Clin Immunol 115: 493-500.
29. Kim SW, Rhee HJ, Ko J, Kim YJ, Kim HG, et al. (2001) Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J Biol Chem 276: 15712-15719.
30. Klapisz E, Masliah J, Bereziat G, Wolf C, Koumanov KS (2000) Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A(2). J Lipid Res 41: 1680-1688.
31. Harder T, Rentero C, Zech T, Gaus K (2007) Plasma membrane segregation during T cell activation: probing the order of domains. Curr Opin Immunol 19: 470-475.
32. Hueber AO (2003) Role of membrane microdomain rafts in TNFR-mediated signal transduction. Cell Death Differ 10: 7-9.
33. Bajmoczi M, Gadjeva M, Alper SL, Pier G, Golan DE (2009) Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am J Physiol Cell Physiol.
34. Kowalski MP, Pier GB (2004) Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 172: 418-425.
35. Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, et al. (2003) Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9: 322-330.
36. Dudez T, Borot F, Huang S, Kwak BR, Ollero M, et al. (2008) CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion. BBA 1783: 779.
37. Vij N, Mazur S, Zeitlin PL (2009) CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4: e4664.
38. Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M (2001) Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Cancer Res 61: 1693-1698.
39. Ayala-Sanmartin J, Gouache P, Henry JP (2000) N-Terminal domain of annexin 2 regulates Ca(2+)-dependent membrane aggregation by the core domain: a site directed mutagenesis study. Biochemistry 39: 15190-15198.
40. Lipecka J, Norez C, Bensalem N, Baudouin-Legros M, Planelles G, et al. (2006) Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J Pharmacol Exp Ther 317: 500-505.
41. Debbaghi A, Hidi R, Vargaftig BB, Touqui L (1992) Inhibition of phospholipase A2 activity in guinea pig eosinophils by human recombinant IL-1 beta. J Immunol 149: 1374-1380.
42. Hughes LK, Li H, Sheppard DN (2004) Use of an iodide-selective electrode to measure CFTR Cl- channel activity. Virtual Repository of Cystic Fibrosis European Network.
43. Ganster RW, Guo Z, Shao L, Geller DA (2005) Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions. J Interferon Cytokine Res 25: 707-719.
44. Moon S, Singh M, Krouse ME, Wine JJ (1997) Calcium-stimulated Cl- secretion in Calu-3 human airway cells requires CFTR. Am J Physiol 273: L1208-1219.
45. Shen BQ, Finkbeiner WE, Wine JJ, Mrsny RJ, Widdicombe JH (1994) Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion. Am J Physiol 266: L493-501.
46. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, et al. (2007) CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 292: L383-395.
47. de Coupade C, Ajuebor MN, Russo-Marie F, Perretti M, Solito E (2001) Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. Am J Pathol 159: 1435-1443.
48. La M, D'Amico M, Bandiera S, Di Filippo C, Oliani SM, et al. (2001) Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. Faseb J 15: 2247-2256.
49. Jupp OJ, Vandenabeele P, MacEwan DJ (2003) Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes. Biochem J 374: 453-461.
50. Grell M, Douni E, Wajant H, Lohden M, Clauss M, et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
51. Meli R, Ferrante MC, Raso GM, Cavaliere M, Di Carlo R, et al. (2000) Effect of fumonisin B1 on inducible nitric oxide synthase and cyclooxygenase-2 in LPS-stimulated J774A.1 cells. Life Sci 67: 2845-2853.
52. Habib A, Shamseddeen I, Nasrallah MS, Antoun TA, Nemer G, et al. (2007) Modulation of COX-2 expression by statins in human monocytic cells. Faseb J 21: 1665-1674.
53. Choi YA, Chin BR, Rhee DH, Choi HG, Chang HW, et al. (2004) Methyl-beta-cyclodextrin inhibits cell growth and cell cycle arrest via a prostaglandin E(2) independent pathway. Exp Mol Med 36: 78-84.
54. Cabrera-Poch N, Sanchez-Ruiloba L, Rodriguez-Martinez M, Iglesias T (2004) Lipid raft disruption triggers protein kinase C and Src-dependent protein kinase D activation and Kidins220 phosphorylation in neuronal cells. J Biol Chem 279: 28592-28602.
55. Hsieh HL, Sun CC, Wang TS, Yang CM (2008) PKC-delta/c-Src-mediated EGF receptor transactivation regulates thrombin-induced COX-2 expression and PGE(2) production in rat vascular smooth muscle cells. Biochim Biophys Acta 1783: 1563-1575.
56. Koumanov KS, Wolf C, Quinn PJ (2004) Lipid composition of membrane domains. Subcell Biochem 37: 153-163.
57. Brouillard F, Fritsch J, Edelman A, Ollero M (2008) Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology. Proteomics - Clinical Applications 2: 264-285.
58. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, et al. (2002) Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658.
59. Wang D, Wang W, Duan Y, Sun Y, Wang Y, et al. (2008) Functional coupling of Gs and CFTR is independent of their association with lipid rafts in epithelial cells. Pflugers Arch 456: 929-938.